Skip to main content
logo
Epigenomics AG (FRA:ECX)
Germany flag Germany · Delayed Price · Currency is EUR
1.150
-0.050 (-4.17%)
Aug 12, 2026, 8:01 AM CET

Epigenomics AG Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.020.02-0.340.96.2
Revenue Growth
500.00%---62.29%-85.51%636.70%
Gross Profit
0.020.02-0.280.436.07
Operating Income
-0.38-0.38-1.19-4.18-11.73-4.16
Net Income
-0.31-0.31-3.35-4.46-17.3-2.43
Earnings Per Share
-0.36-0.36-3.82-5.23-21.28-4.33
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.410.410.932.17.823.05
Total Debt
11.3811.3811.3811.8912.660.46
Net Cash (Debt)
-10.97-10.97-10.46-9.79-4.8522.59
Net Cash Growth
-----487.64%
Net Cash Per Share
-12.51-12.51-11.92-11.47-5.9740.31

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.53-0.53-1.2-5.71-10.63-4.15
Capital Expenditures
-----0.09-0.04
Free Cash Flow
-0.53-0.53-1.2-5.71-10.71-4.19
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-83.19%47.27%97.81%
Operating Margin
-1591.67%-1591.67%--1232.15%-1304.56%-67.10%
Pretax Margin
-1308.33%-1308.33%--1316.81%-1924.81%-38.85%
Profit Margin
-1308.33%-1308.33%--1316.81%-1924.80%-39.14%
FCF Margin
-2220.83%-2220.83%--1684.66%-1191.77%-67.50%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
42.0232.89-4.687.511.32